On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Healthcare Coalition Decries FDA Approval of Extended-Release Zohydro
A 40-member coalition partly comprised of physician experts on opioid addiction treatment and overdose prevention is asking the US Food and Drug Administration to rescind its approval of extended-release Zohydro (hydrocodone bitratrate), given the drug's perceived dangers to the public.
Metabolic Changes Accelerate Cognitive Decline in Type 2 Diabetics
March 3rd 2014Examining evidence from epidemiologic, clinical, and animal studies, a team of researchers discussed the connection between neural dysfunction and metabolic disorders related to type 2 diabetes in the February 2014 issue of Current Diabetes Reports.
Low Vitamin D Levels in Pregnancy Linked to Increased Gestational Diabetes Risk
February 27th 2014New study results suggest low levels of vitamin during the first trimester are a modest yet consistent and independent risk factor for developing gestational diabetes and are associated with insulin resistance at the second trimester.
Alzheimer's Agitation Eased by Citalopram, But With Severe Adverse Effects
In a recent clinical trial, Celexa (citalopram) reduced agitation in patients with probable Alzheimer's disease (AD) compared to placebo, but the drug also produced severe cognitive and cardiac adverse events that prescribers must consider.
Ear Drops Beat Oral Medications in Children With Tympanostomy-Tube Otorrhea
A new study suggests antibiotic-glucocorticoid ear drops are superior to oral medications in children who suffer from acute otorrhea following the insertion of tympanostomy tubes for recurrent ear infections.
FDA Updates Warning Label for Hepatitis C Antiviral Drug
February 19th 2014The Food and Drug Administration has updated a drug warning label and medication guide for Victrelis (boceprevir) after receiving reports of abnormally low levels of red and white blood cells in patients who received it as part of combination treatment for hepatitis C.
FDA Panel Votes Against Naproxen's Cardiovascular Safety Claim
A US Food and Drug Administration (FDA) advisory panel has not found enough clinical evidence to conclude that naproxen presents a lower risk of cardiovascular (CV) thrombotic events than other nonsteroidal anti-inflammatory drugs (NSAIDs).
Late-Onset Alzheimer's Disease in Both Parents May Boost Dementia Risk in Adult Offspring
Patients who are free of dementia but have 2 parents with late-onset Alzheimer's disease may show signs of the disease in brain scans several years, if not decades, before they display clinical symptoms.